NI
ZBH icon

Nuance Investments’s Zimmer Biomet ZBH Stock Holding History

Nuance Investments’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-975,056
Closed -$109M – 59
2023
Q3 		$109M Buy
975,056
+51,306
+6% +$6.52M 2.68% 13
2023
Q2 		$134M Sell
923,750
-250,876
-21% -$34.1M 2.87% 13
2023
Q1 		$152M Buy
1,174,626
+1,035,597
+745% +$130M 3.21% 11
2022
Q4 		$17.7M Buy
139,029
+96,513
+227% +$11.2M 0.37% 37
2022
Q3 		$4.45M Sell
42,516
-423,712
-91% -$46.5M 0.1% 45
2022
Q2 		$49M Sell
466,228
-2,058,875
-82% -$244M 0.97% 28
2022
Q1 		$323M Buy
2,525,103
+450,259
+22% +$54.3M 5.78% 5
2021
Q4 		$256M Buy
2,074,844
+740,337
+55% +$96.9M 4.5% 7
2021
Q3 		$190M Buy
1,334,507
+466,029
+54% +$68.6M 3.47% 12
2021
Q2 		$136M Buy
+868,478
New +$141M 2.42% 15
2016
Q2 		– Sell
-11,170
Closed -$1.16M – 66
2016
Q1 		$1.16M Buy
11,170
+3,179
+40% +$308K 0.13% 52
2015
Q4 		$796K Buy
7,991
+375
+5% +$36.7K 0.09% 48
2015
Q3 		$695K Buy
+7,616
New +$763K 0.08% 51

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuance Investments's ZBH Position: Q4 2023 in Review

Nuance Investments sold out of Zimmer Biomet (ZBH) in Q4 2023, closing a stake of 975,056 shares — an estimated $109M sold.

Nuance Investments first reported a position in ZBH in Q3 2015 and held it in 13 quarters. The position peaked at $323M in Q1 2022. 1,030 funds tracked by Wall St. Rank hold ZBH as of Q4 2023.

  • Nuance Investments reported no remaining Zimmer Biomet position as of Q4 2023 after selling out during the quarter.
  • Nuance Investments sold 975,056 Zimmer Biomet shares in Q4 2023, an estimated $109M.
  • Nuance Investments first reported a position in Zimmer Biomet in Q3 2015 and held it in 13 quarters.
  • Nuance Investments's Zimmer Biomet position peaked at $323M in Q1 2022.
  • 1,030 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2023.

Based on Nuance Investments's 13F filing for Q4 2023, filed 7 Feb 2024.